Bristol Myers Squibb to present 60+ oncology studies at ASCO 2026
Go back to Bristol Myers Squibb to present 60+ oncology studies at ASCO 2026| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.56 -0.39 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.95 | 52 Week High | $77.12 | |||
| Open | $66.77 | 52 Week Low | $49.03 | |||
| Day High | $66.84 | P/E | 43.22 | |||
| Day Low | $66.24 | EPS | $1.54 | |||
| Volume | 1,133,915 | |||||
